Ionis Pharmaceuticals, Inc. Amortization of Debt Issuance Costs and Discounts
Ionis Pharmaceuticals, Inc. (IONS) reported Amortization of Debt Issuance Costs and Discounts of $4.90 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2022-02-25
- Ionis Pharmaceuticals, Inc. amortization of debt issuance costs and discounts for fiscal 2021 was $4.90M, a 53.13% increase from fiscal 2020.
- Ionis Pharmaceuticals, Inc. amortization of debt issuance costs and discounts for fiscal 2020 was $3.20M, a 10.34% increase from fiscal 2019.
- Ionis Pharmaceuticals, Inc. amortization of debt issuance costs and discounts for fiscal 2019 was $2.90M, a 91.76% decline from fiscal 2018.
- Ionis Pharmaceuticals, Inc. amortization of debt issuance costs and discounts for fiscal 2018 was $35.20M, a 8.31% increase from fiscal 2017.
| Period end | Amortization of Debt Issuance Costs and Discounts 12 month | Amortization of Debt Issuance Costs and Discounts 12 month as first filed |
|---|---|---|
| 2021-12-31 | $4.90M 10-K · filed 2022-02-25 | |
| 2020-12-31 | $3.20M 10-K · filed 2022-02-25 | $38.70M 10-K · filed 2021-02-24 |
| 2019-12-31 | $2.90M 10-K · filed 2022-02-25 | $39.30M 10-K · filed 2020-03-02 |
| 2018-12-31 | $35.20M 10-K · filed 2021-02-24 | |
| 2017-12-31 | $32.50M 10-K · filed 2020-03-02 | |
| 2016-12-31 | $25.10M 10-K · filed 2019-03-01 | |
| 2015-12-31 | $23.20M 10-K · filed 2018-02-28 | |
| 2014-12-31 | $9.60M 10-K · filed 2017-03-01 | |
| 2013-12-31 | $6.80M 10-K · filed 2016-02-26 | |
| 2012-12-31 | $9.80M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |